Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 7Gastrointestinal 4Genitourinary 3Thoracic 2Gynecologic 2Tumor-Agnostic 1Sarcoma 1Other solid neoplasm 1Other 1Lymphoid 1Endocrine 1

Conditions

Uterine Neoplasms 1Obesity 1Neoplasms 1Motor Activity 1Endometrial Neoplasms 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Biomarkers × Gynecologic × Clear all
NCT01870947 2020-01-27

Assisted Exercise in Obese Endometrial Cancer Patients

Case Comprehensive Cancer Center

Phase NA Completed
95 enrolled
GynecologicOther

Motor Activity, Neoplasms, Obesity, Uterine Neoplasms

NCT02543710 2017-03-28

Momatec2

Haukeland University Hospital

Phase 4 Recruiting
1,300 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡